Venrock Healthcare Capital Partners III, L.P. (CIK 0001738048)

Latest company ownership

Shares held
20,637,286
Last filed at
Jul 14, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
5,303,985
Last filed at
Apr 11, 2025
Confidence Score
51.3
2025Q4
Confidence Score History
2019Q1 2025Q4
Shares held
4,355,273
Last filed at
Aug 18, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
4,148,428
Last filed at
Feb 27, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2025Q1 2025Q4
ALT - Altimmune, Inc.
Role: 10% Owner
Shares held
1,000,000
Last filed at
Mar 1, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 9, 2025 Apr 11, 2025 KalVista Pharmaceuticals, Inc. 10% Owner Buy 65.0 +25,000 0.47% ✗ $235.5K
Feb 10, 2025 Feb 27, 2025 Oruka Therapeutics, Inc. 10% Owner Buy 92.5 +122,882 3.05% ✗ $1.4M
Feb 12, 2025 Feb 14, 2025 KalVista Pharmaceuticals, Inc. 10% Owner Buy 92.5 +161,700 3.16% ✗ $1.5M
Feb 7, 2025 Feb 11, 2025 KalVista Pharmaceuticals, Inc. 10% Owner Buy 85.0 +104,489 2.08% ✗ $967.1K
Jan 30, 2025 Feb 3, 2025 KalVista Pharmaceuticals, Inc. 10% Owner Buy 85.0 +70,023 1.42% ✗ $621.6K
Feb 6, 2024 Feb 8, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 87.5 +86,048 1.82% ✗ $1.3M
Jan 30, 2024 Feb 1, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 87.5 +88,099 1.89% ✗ $1.3M
Jan 25, 2024 Jan 29, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 87.5 +91,804 2.01% ✗ $1.3M
Jan 22, 2024 Jan 24, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 87.5 +99,129 2.22% ✗ $1.2M
Jan 17, 2024 Jan 19, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 92.5 +143,605 3.33% ✗ $1.8M
Jan 11, 2024 Jan 16, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 75.0 +26,246 0.61% ✗ $333.8K
Jan 8, 2024 Jan 10, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 92.5 +137,700 3.32% ✗ $1.7M
Jan 3, 2024 Jan 5, 2024 KalVista Pharmaceuticals, Inc. 10% Owner Buy 85.0 +59,369 1.45% ✗ $720.5K
Dec 27, 2023 Dec 29, 2023 KalVista Pharmaceuticals, Inc. 10% Owner Buy 100.0 +519,017 14.52% ✗ $6.5M
Jul 12, 2022 Jul 14, 2022 Vistagen Therapeutics, Inc. 10% Owner Sell 40.0 -60,000 -0.29% ✗ $53.4K
Aug 14, 2020 Aug 18, 2020 Cogent Biosciences, Inc. 10% Owner Buy 100.0 +451,000 11.55% ✗ $1.1M
Jun 15, 2020 Jun 15, 2020 Altimmune, Inc. 10% Owner Buy 100.0 +1,500,000 50.00% ✗ $11.3M
May 26, 2020 May 28, 2020 Altimmune, Inc. 10% Owner Buy 100.0 +1,303,636 76.85% ✗ $11.4M
Mar 18, 2019 Mar 20, 2019 KalVista Pharmaceuticals, Inc. 10% Owner Sell 15.0 -500,000 -24.46% ✗ $14.4M